Target intelligence / Profile preview

Elongin C pseudogene 18 (ELOCP18)

Target
ELOCP18
Molecular classification
Other (pseudogene)
01

Overview

Elongin C pseudogene 18 (ELOCP18) is annotated as a processed pseudogene located at chromosome 1p31.3, spanning base pairs 68375327–68375663 on the human genome[2][3][4]. It is derived from the Elongin C gene, which encodes a subunit of the transcription elongation factor B (SIII) complex that regulates RNA polymerase II, but ELOCP18 itself does not encode a functional protein. There are no reported biological functions, disease associations, or known mechanisms of action for drugs, as ELOCP18 is not biologically active. Its nomenclature reflects its origin from the elongin C gene family but does not imply functional activity or therapeutic relevance[4]. If you are seeking information for a druggable target, ELOCP18 is not considered valid; the canonical protein-coding target would be "Elongin C" (abbreviated as ELOC), a legitimate component of the transcription elongation machinery and E3 ubiquitin ligase complexes[1][9].

Other names
TCEB1P18transcription elongation factor B (SIII), polypeptide 1 pseudogene 18transcription elongation factor B subunit 1 pseudogene 18ELOCP18

Beyond the preview

Go deeper on Elongin C pseudogene 18 (ELOCP18).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Elongin C pseudogene 18 (ELOCP18).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call